Advanced search

Investors

Latest corporate press releases

[an error occurred while processing this directive] [an error occurred while processing this directive]

23 August 2010
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles

Latest documents


Presentation and webcasts

John Clarke, President, Worldwide Consumer Healthcare, along with senior members of his management team presented on GSK's Consumer Healthcare business to a small group of investors in London on 23 June 2010.  

GSK announces Q2 results 2010

21 July 2010

Andrew Witty, CEO
  • Q2 EPS before major restructuring 2.6p (29.3p excluding pre-announced legal charge)


Financial calendar

Forthcoming events in our financial calendar

  • 21 Oct 2010 - Q3 results


More key financial dates

Share price

LSE
1,269p
7.00

03 Sep 2010 04:49 pm BST
NYSE
39.29
0.34

03 Sep 2010 04:01 pm EDT
London Stock Exchange price updated every 15 minutes. Provided by Investis Limited.

Investors

Annual Report

Go to the Annual Report 2009

GSK Q2 results 2010

CEO Andrew Witty talks about latest progress of GSK’s strategic priorities:

Q2 results announcement

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

GSK's strategic priorities


 

Share price analysis

 


 

Product pipeline

Building the best product pipeline in the business

We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.

Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.

Find out more about our pipeline